Tonix Pharmaceuticals Holding Corp.
TNXP
$12.83
-$0.33-2.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -96.10% | -11.72% | 4.63% | 26.64% | 45.36% |
| Total Depreciation and Amortization | -14.46% | -31.58% | -43.73% | -56.31% | -43.49% |
| Total Amortization of Deferred Charges | 100.00% | -100.00% | -92.26% | -34.08% | -102.79% |
| Total Other Non-Cash Items | -26.29% | -83.97% | -80.02% | -82.23% | -83.72% |
| Change in Net Operating Assets | -175.59% | 578.84% | 79.77% | 4,116.55% | -49.92% |
| Cash from Operations | -135.94% | -109.55% | -63.88% | -9.02% | 11.44% |
| Capital Expenditure | -838.53% | -27,983.33% | -2,707.50% | -169.91% | 76.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 142.40% | -- | -- | -- | -- |
| Cash from Investing | -66.68% | -34,422.22% | -3,673.33% | -540.51% | -88.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | -310.64% | -529.48% | -1,076.60% |
| Issuance of Common Stock | 4.38% | -4.18% | 67.29% | 282.90% | 599.11% |
| Repurchase of Common Stock | -31.30% | -251.59% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.91% | 42.79% | 14.53% | -166.06% | -154.53% |
| Cash from Financing | 10.14% | 0.32% | 59.06% | 165.99% | 250.52% |
| Foreign Exchange rate Adjustments | -1,166.67% | -1,500.00% | -875.00% | 123.33% | 76.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -58.42% | -57.18% | 49.16% | 664.48% | 682.51% |